![Yeol-Hong Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 480 797 $ al 30/09/2026
Dr. Yeol-Hong Kim is a Co-President, Executive Director, Head-R&D at Yuhan Corp.
He is on the Board of Directors at ProGen Co., Ltd., Immuneoncia Therapeutics, Inc. and Yuhan Corp.
Dr. Kim was previously employed as a Non-Executive Director by Aprilbio Co. Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
YUHAN CORPORATION 0,01 % | 01/10/2026 | 8.939 ( 0,01 % ) | 480 797 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| YUHAN CORPORATION | Presidente | 15/03/2024 |
| PROGEN CO., LTD. | Director/Miembro de la Junta | 28/03/2024 |
| IMMUNEONCIA THERAPEUTICS, INC. | Director/Miembro de la Junta | 26/12/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| APRILBIO CO.,LTD. | Director/Miembro de la Junta | 31/10/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Yuhan Corp.
 Yuhan Corp. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and marketing of pharmaceutical products | Health Technology |
Aprilbio Co. Ltd.
 Aprilbio Co. Ltd. BiotechnologyHealth Technology Operates as a drug development bio company | Health Technology |
Immuneoncia Therapeutics, Inc.
 Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients | Health Technology |
Progen Co., Ltd.
 Progen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medical sciences and pharmacy products | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
